(IN BRIEF) BioNTech and OncoC4 have entered into an exclusive license and collaboration agreement to develop and commercialize OncoC4's anti-CTLA-4…
BIRMINGHAM, 19-Apr-2017 — /EuropaWire/ — A new study has identified novel mechanisms whereby T cells may be able to distinguish an…
16-8-2013 — /EuropaWire/ — Immunologists at LMU have come up with a new technique that can be used both to fight…
06-8-2013 — /EuropaWire/ — Researchers at Karolinska Institutet in Sweden have identified a new stabilizing agent of atherosclerotic plaques. These findings…